T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALD
851
DELISTED
Callidus Software, Inc.
CALD
| $51.2M | 0.01% |
1,786,411
-62,110
| -3% | -$1.69M |
|
852
Kinsale Capital Group
KNSL
$8.59B
| $50.9M | 0.01% |
1,132,028
-44,730
| -4% | -$1.95M |
|
853
The Ensign Group
ENSG
$10.6B
| $50.9M | 0.01% |
2,448,615
-122,051
| -5% | -$2.62M |
|
|
AGU
854
DELISTED
Agrium
AGU
| $50.8M | 0.01% |
442,031
-14,879
| -3% | -$1.61M |
|
|
CERN
855
DELISTED
Cerner Corp
CERN
| $50.8M | 0.01% |
753,140
-21,349
| -3% | -$1.48M |
|
856
Methode Electronics
MEI
$593M
| $50.4M | 0.01% |
1,256,232
-39,610
| -3% | -$1.76M |
|
857
Univest Financial
UVSP
$1.19B
| $50.4M | 0.01% |
1,795,366
+1,080,404
| +151% | +$32M |
|
858
Primerica
PRI
$9.62B
| $50.3M | 0.01% |
494,976
+106,234
| +27% | +$10.1M |
|
859
ICU Medical
ICUI
$4.58B
| $50.1M | 0.01% |
232,168
-4,737
| -2% | -$959K |
|
|
APC
860
DELISTED
Anadarko Petroleum
APC
| $50.1M | 0.01% |
934,409
-33,220
| -3% | -$1.63M |
|
861
argenx
ARGX
$53.6B
| $50.1M | 0.01% |
793,481
+418,344
| +112% | +$13.7M |
|
862
RingCentral
RNG
$5.66B
| $50.1M | 0.01% |
1,034,755
-92,330
| -8% | -$4.2M |
|
863
Penumbra
PEN
$12.9B
| $50.1M | 0.01% |
532,203
+47,893
| +10% | +$4.75M |
|
|
JUNO
864
DELISTED
Juno Therapeutics, Inc.
JUNO
| $50.1M | 0.01% |
1,095,263
-35,542
| -3% | -$1.77M |
|
865
Galicia Financial Group
GGAL
$7.23B
| $50M | 0.01% |
759,697
+40,310
| +6% | +$2.31M |
|
|
ESGR
866
DELISTED
Enstar Group
ESGR
| $50M | 0.01% |
249,022
+1,017
| +0.4% | +$227K |
|
867
St. Joe Company
JOE
$3.89B
| $50M | 0.01% |
2,768,492
+31,042
| +1% | +$575K |
|
868
ScottsMiracle-Gro
SMG
$3.59B
| $49.9M | 0.01% |
466,182
-1,685
| -0.4% | -$168K |
|
869
Live Nation Entertainment
LYV
$43.3B
| $49.8M | 0.01% |
1,170,780
-5,560
| -0.5% | -$242K |
|
870
Badger Meter
BMI
$3.78B
| $49.8M | 0.01% |
1,041,957
-103,315
| -9% | -$4.79M |
|
871
Equity Lifestyle Properties
ELS
$12.6B
| $49.8M | 0.01% |
1,117,950
-68,306
| -6% | -$3.04M |
|
872
Dorman Products
DORM
$3.95B
| $49.6M | 0.01% |
811,061
-28,728
| -3% | -$1.95M |
|
873
Paychex
PAYX
$44.6B
| $49.6M | 0.01% |
728,152
-24,837
| -3% | -$1.63M |
|
874
Rush Enterprises Class A
RUSHA
$9.62B
| $49.4M | 0.01% |
2,186,096
-859,477
| -28% | -$18.7M |
|
|
HAYN
875
DELISTED
Haynes International, Inc.
HAYN
| $49.2M | 0.01% |
1,536,613
+9,160
| +0.6% | +$312K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.